1. Prostate carcinoma and green tea: (−)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model
- Author
-
Fiorella Calabrese, Monica Morini, Massimo Donà, Spiridione Garbisa, Isabella Dell'Aica, Elga Pezzato, Luigi Sartor, and Adriana Albini
- Subjects
chemistry.chemical_classification ,Cancer Research ,medicine.medical_specialty ,Matrigel ,Phagocyte ,Cell growth ,Flavonoid ,food and beverages ,Inflammation ,Catechin ,Biology ,complex mixtures ,chemistry.chemical_compound ,medicine.anatomical_structure ,Endocrinology ,Oncology ,chemistry ,In vivo ,Internal medicine ,medicine ,Cancer research ,medicine.symptom ,Tramp - Abstract
Green tea infusion has been shown to inhibit metastatic spreading of the transgenic adenocarcinoma of mouse prostate (TRAMP). Investigation on the molecular mechanisms triggered by the main green tea flavonoid, (-)epigallocatechin-3-gallate (EGCG), shows that EGCG restrains TRAMP-C1 cell proliferation in a dose-dependent manner, at concentrations (IC(50) 50%). In vivo, s.c. injection of TRAMP-C1 cells dispersed in Matrigel gives origin to a tumor mass, whose growth is not inhibited by green-tea regimen. This growth is contained greater than two-thirds by LPS-triggered polymorpho-nuclear phagocyte (PMN) recruitment but this effect is abolished by green tea. Nevertheless, while tumor-released pro-MMP-2 is activated by co-incubation of TRAMP-C1 cells with PMNs, in the presence of 10 microM EGCG the activation is almost abolished. These results suggest that inflammatory involvement of prostate carcinoma could be efficaciously prevented by green tea with a concomitant lowering of the invasive potential.
- Published
- 2004
- Full Text
- View/download PDF